Chemistry: molecular biology and microbiology – Process of utilizing an enzyme or micro-organism to destroy... – Resolution of optical isomers or purification of organic...
Patent
1998-12-15
2000-10-24
Saucier, Sandra E.
Chemistry: molecular biology and microbiology
Process of utilizing an enzyme or micro-organism to destroy...
Resolution of optical isomers or purification of organic...
106121, C07C 104, C12P 1304, C12P 1710
Patent
active
061365912
DESCRIPTION:
BRIEF SUMMARY
FIELD OF THE INVENTION
This invention relates to a novel resolution method which is useful in the production of enantiomerically-pure azetidine-2-carboxylic acid, especially enantiomerically-pure (S)-azetidine-2-carboxylic acid.
BACKGROUND OF THE INVENTION
Azetidine-2-carboxylic acid is an unusual amino acid, the (S)-enantiomer of which is known to be useful in the synthesis of inter alia high molecular weight polypeptides, and in particular as an analogue of the well known amino acid proline.
This amino acid is of limited availability from natural sources, and in nature is found only as the (S)-enantiomer. The development of an efficient and economic synthetic method for producing both the pure racemic compound and either of the individual (R)- or (S)-single enantiomers is therefore desirable.
Previously documented chiral syntheses of (S)-azetidine-2-carboxylic acid include a five step preparation via homoserine lactone, starting from N-tosyl protected L-methionine (see for example Japanese Patent Application N.sup.o 14457/74 and Bull. Chem. Soc. Jpn. (1973) 46, 699) and a five step preparation via L-4-amino-2-chlorobutyric acid, starting from L-2,4-diaminobutyric acid (see Biochem. J. (1956) 64, 323).
Previously documented preparations of enantiomerically-pure azetidine-2-carboxylic acid from the racemate involve long and relatively complicated multi-step methodology.
For example, a four step preparation involving the protection, resolution and subsequent deprotection of racemic azetidine-2-carboxylic acid is known from J. Heterocyclic Chem. (1969) 6, 993. In this method, N-carbobenzyloxy-protected racemic azetidine-2-carboxylic acid is resolved using L-tyrosine hydrazide as resolution agent, and then isolated before a final deprotection step. This process has the further disadvantage that L-tyrosine hydrazide is expensive.
Such methods present the problem that they are typically cumbersome because of the need to recycle the resolving agent and inevitably only produce half of the material as the required isomer. For an economic overall process it thus becomes necessary to find a method for the recycling of the unwanted isomer, and for this to be integrated into a process with the minimum of extra chemical steps.
Moreover, racemic azetidine-2-carboxylic acid obtained via chemical synthesis inevitably contains contaminants. Thus a resolution procedure which produces only the required single enantiomer, as well as being more economic, is also expected to facilitate chemical purification of the product.
Bioresolution is a procedure which is known to be of use generally in the production of enantiomerically-pure compounds. However, the potential utility and effectiveness of the technique in the resolution of a particular chiral compound is difficult to predict.
No biocatalytic resolution method has been previously disclosed for azetidine-2-carboxylic acid. Moreover, no resolution has been disclosed for azetidine-2-carboxylic acid which integrates recycling of the unwanted isomer in an efficient manner and which takes account of impurities arising from the racemate synthesis.
We have now surprisingly found that enantiomerically enriched azetidine-2-carboxylic acid may be obtained in an extremely enantiomerically-pure form, and in extremely high yields, via a novel and efficient bioresolution process.
DESCRIPTION OF THE INVENTION
According to the invention there is provided a process for obtaining an enantiomerically enriched N-acylazetidine-2-carboxylic acid, which process comprises the biotransformation of a racemic N-acylazetidine-2-carboxylic acid ester with an enzyme that displays enantiospecificity (hereinafter referred to as "the process according to the invention").
The term "enantiomerically enriched" when used herein means any mixture of the enantiomers of an N-acylazetidine-2-carboxylic acid in which one enantiomer is present in a greater proportion than the other, for example mixtures with an enantiomeric purity (enantiomeric excess; e.e.) of greater than 50%, preferably at least 70% and more
REFERENCES:
C.R. Johnson et al.: "Enzymic asymmetrization of meso-2-cycloalken-1, 4-diols and their diacetates in organic and aqueous media" Tetrahedron Letters, vol. 33, No. 48, 1992, pp. 7287-7290.
R.M. Rodebaugh et al.: "Resolution of DL-Azetidine-2-carboxylic acid" Journal of Heterocyclic Chemistry, vol. 6, No. 6, 1969, pp. 993-994.
Parratt Julian Simon
Taylor Stephen John C.
Astra AB
Saucier Sandra E.
LandOfFree
Bioresolution of N-acylazetidine-2-carboxylic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bioresolution of N-acylazetidine-2-carboxylic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioresolution of N-acylazetidine-2-carboxylic acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1962432